LIANBIO |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.315 USD | +5.00% |
|
+8.58% | -92.95% |
| 05-10 | China's Zeekr prices US IPO at top of range to raise $441 million | RE |
| 05-07 | Geely's EV Unit Zeekr Targets Up to $367.5 Million From NYSE IPO | MT |
Chart calendar LianBio
7628f8fe1f2.ahu8Ofu1RYMDBD-p5nhr8mHyvUVraNle0RlcduRihD0.PnT2bKH3KvRKTErvqAsClSO-2CQxOL4Uslg5FI9b4Q86fOYPttIDwGxTBw~827da84797e005ce10c5087e190f3643
Upcoming events on LianBio
Past events on LianBio
| 13/11/2023 21:05 | Q3 2023 Earnings Release |
| 28/08/2023 16:00 | European Society of Cardiology Congress |
| 14/08/2023 21:05 | Q2 2023 Earnings Release |
| 21/06/2023 13:00 | Annual General Meeting |
| 15/06/2023 18:00 | Goldman Sachs Global Healthcare Conference - Fireside Chat |
| 08/06/2023 21:30 | Jefferies Global Healthcare Conference - Fireside Chat |
| 11/05/2023 21:15 | Q1 2023 Earnings Release |
| 01/05/2023 13:00 | Business Update Call |
| 27/03/2023 13:36 | Q4 2022 Earnings Release |
| 16/11/2022 21:15 | BioCentury-BayHelix East-West Biopharma Summit - Panel |
| 16/11/2022 10:55 | Jefferies London Healthcare Conference |
| 15/11/2022 22:48 | BioCentury-BayHelix East-West Biopharma Summit |
| 15/11/2022 17:00 | BioCentury-BayHelix East-West Biopharma Summit - Panel |
| 15/11/2022 01:00 | Goldman Sachs Asia Pacific Healthcare Forum - Panel |
| 10/11/2022 21:05 | Q3 2022 Earnings Release |
| 11/08/2022 21:05 | Interim 2022 Earnings Release |
| 15/06/2022 22:40 | Goldman Sachs Global Healthcare Conference |
| 10/06/2022 16:00 | Jefferies Healthcare Conference |
| 12/05/2022 14:20 | Bank of America Healthcare Conference |
| 12/05/2022 13:00 | Q1 2022 Earnings Release |
Past dividends on LianBio
| 14/03/2024 | 4.75 USD |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 |
|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 6,67 - |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -195 -209 6.83% | -124 -123 -1.26% |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -196 -206 5.09% | -125 -126 0.31% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -196 -198 1.16% | -111 -114 2.56% |
|
Net income Million USD | Released Forecast Spread | -140 | -196 -204 3.94% | -110 -118 6.3% |
|
EPS USD | Released Forecast Spread | -67,7 | -5,71 -4,51 -26.7% | -1,02 -1,23 17.3% |
| Announcement Date | 09/08/21 | 30/03/22 | 27/03/23 |
Quarterly results
| Fiscal Period | December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 |
|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 6,67 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
|
EBITDA Million USD | Released Forecast Spread | -13,3 -39,1 66.02% | -21,8 -35,8 39.05% | -28,1 -23,0 -22.37% | -43,0 -29,0 -48.29% | -23,5 -44,3 47.06% | -28,9 -5,01 -477.41% | -25,6 -31,7 18.97% | -24,7 -32,0 22.77% | -26,0 -36,1 27.98% |
|
EBIT Million USD | Released Forecast Spread | -13,5 -22,2 39.1% | -22,0 -32,6 32.46% | -60,5 -24,4 -148.4% | -43,1 -29,1 -48.06% | -24,5 -42,4 42.14% | -29,2 -29,6 1.34% | -26,0 -29,9 13.28% | -25,0 -32,1 22.03% | -26,3 -36,4 27.71% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -13,5 -20,0 32.47% | -22,2 -24,6 9.52% | -60,6 -23,6 -156.47% | -42,4 -30,3 -39.96% | -21,9 -44,4 50.72% | -18,6 -20,3 8.45% | -23,6 -32,0 26.25% | -21,4 -25,6 16.28% | -23,5 -24,3 3.49% |
|
Net income Million USD | Released Forecast Spread | -13,1 -30,7 57.29% | -21,2 -30,3 29.95% | -61,6 -22,0 -179.99% | -42,4 -30,6 -38.66% | -21,9 -45,0 51.33% | -18,3 -22,9 20.24% | -24,0 -29,0 17.11% | -21,6 -28,9 25.27% | -24,0 -29,5 18.6% |
|
EPS USD | Released Forecast Spread | -0,63 -0,35 -81.73% | -0,28 -0,33 15.15% | -3,01 -0,26 -1057.69% | -0,39 -0,28 -37.65% | -0,20 -0,42 52% | -0,17 -0,22 21.54% | -0,22 -0,27 19.51% | -0,20 -0,27 25.93% | -0,22 -0,29 22.81% |
| Announcement Date | 09/12/21 | 30/03/22 | 12/05/22 | 11/08/22 | 10/11/22 | 27/03/23 | 11/05/23 | 14/08/23 | 13/11/23 |
More events
Past sector events for LianBio
| 05/06/2024 08:51 | PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release |
| 17/05/2024 12:00 | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
| 16/05/2024 12:46 | BIOCON LIMITED: Q4 2024 Earnings Release |
| 16/05/2024 06:00 | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
| 15/05/2024 | LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release |
| 15/05/2024 13:05 | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
| 15/05/2024 12:00 | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
| 14/05/2024 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
| 14/05/2024 21:05 | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 14/05/2024 21:00 | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- LIANY Stock
- Calendar LianBio
